Contracts + Grants New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health EmergenciesGlobal Biodefense StaffAugust 27, 2024
Medical Countermeasures Disappointing Results for Tecovirimat Mpox Trial in the DRCGlobal Biodefense StaffAugust 15, 2024
Medical Countermeasures Lassa Fever Vaccine Study Supports Advancement to Phase I TrialGlobal Biodefense StaffAugust 14, 2024
Regeneron Awarded $325M for Development of Next-Gen COVID-19 Monoclonal Antibody Therapy Industry News August 22, 2023 …
Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development Contracts + Grants August 22, 2023 …
RedHill Biopharma Highlights Federal Medical Countermeasure Investments Industry News August 17, 2023 …
Treatments for Poxviruses May Already Exist in Licensed Drugs Medical Countermeasures August 9, 2023 …
U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions Industry News July 31, 2023 …
After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure Industry News July 28, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine Medical Countermeasures July 20, 2023 …
VitriVax Wins DoD Contract to Develop Single-Shot Vaccine for Melioidosis and Glanders Industry News July 19, 2023 …
DARPA Award to Ginkgo Bioworks Aims to Revolutionize Speed of Medical Countermeasure Manufacturing Industry News July 19, 2023 …
NIAID Awards Multiple Contracts for Radiation Medical Countermeasures and Biodosimetry CBRNE July 9, 2023 …
Revive Therapeutics Announces Results of Phase 3 Study for Bucillamine in the Treatment of COVID-19 Industry News July 6, 2023 …
UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness Contracts + Grants May 26, 2023 …
A-Alpha Bio and Lawrence Livermore to Accelerate Antibody Discovery and Development for Biothreats Industry News May 16, 2023 …
